500 ARSENAL STREET, WATERTOWN, MA
Enanta Pharmaceuticals Enters Open Market Sale Agreement with Jefferies
Other Events
Reg. FD
Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2026
Stockholders Approve Amendment to 2019 Equity Incentive Plan
Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
Annual Report to Security Holders
Q2
Q1
FY 2024
Q3
FY 2023
Prospectus filed pursuant to Rule 424(b)(5)
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence